New York Jets quarterback Aaron Rodgers pledged $3 million toward Enloe Health's upcoming comprehensive cancer center in Chico, Calif., the Enterprise-Record reported April 9.

Boston-based Dana-Farber Cancer Institute has retracted an additional study in the midst of an investigation into research that may include manipulated or duplicated images, NBC News reported April 9.

Accelerated biological aging may be a factor in rising cancer rates among younger adults, new findings from researchers at the Washington University School of Medicine in St. Louis suggest. 

By 2050, new cancer diagnoses are expected to reach 35 million worldwide — up from the 20 million cases diagnosed in 2022, according to the American Cancer Society's 2024 report on global cancer statistics. 

A recent study by researchers at Brigham and Women's Hospital and Harvard Medical School, both based in Boston, found only 43% of cancer drugs granted accelerated FDA approval demonstrated clinical benefit in confirmatory trials.

Los Angeles-based Keck Medicine of USC will assess the feasibility of providing home-based immunotherapy to patients with non-small cell lung cancer via a new clinical trial.

In the U.S., 1 in 5 people with cancer participate in some form of clinical research, according to the first report to estimate participation levels across all types of cancer studies. 

The University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has named Yong Zhu, PhD, associate director for population science and translational science, the Little Rock-based organization said April 2.

Approximately 81% of oncologists said patients should consent to artificial intelligence use for cancer treatment decisions, a recent survey found.

The Oncology Nursing Society honored five nurses and a cancer center for excellence.

Philadelphia-based Fox Chase Cancer Center has expanded to New Jersey with its first oncology office.

Making sure adults with cancer are up to date on recommended vaccinations should be a key part of their care to prevent or limit the severity of infections, the American Society of Clinical Oncology said in updated guidelines published March 18. 

New York City-based NYU Langone Health's Perlmutter Cancer Center launched a phase 3 trial for its metastasis melanoma mRNA vaccine.

New York City-based NYC Health + Hospitals screened more than 50,000 patients for colorectal cancer in 2023 using an at-home fecal immunochemical test.

Little Rock-based University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute received an $11.48 million federal grant to create the Center for Molecular Interactions in Cancer.

Research continues to uncover the significant ways in which COVID-19 has disrupted cancer care, with new findings showing colorectal cancer surgeries fell 17.3% in the first year of the pandemic. 

A genetic test could stop some patients from overdosing on a chemotherapy drug, but only 3% of oncologists are testing patients, KFF Health News reported March 26.

In revealing a cancer diagnosis March 22, Kate Middelton said the cancer was detected following a surgical procedure — something oncologists say they encounter frequently.

Seattle-based Fred Hutchinson Cancer Center researchers found a blood test could detect colorectal cancer with 83.1% accuracy.

Tarrytown, N.Y.-based Regeneron Pharmaceuticals said the FDA declined to approve its blood cancer therapy for two forms of lymphoma over concerns about the ongoing confirmatory trials.